What is KW-2449 used for?

KW-2449 is being researched as a possible treatment for acute myeloid leukemia.

Is KW-2449 an approved medication?

No, KW-2449 is currently in Phase 1 clinical trials and is not yet approved for medical use.

What type of drug is KW-2449?

KW-2449 is classified as a small molecule drug.

What should I know about KW-2449's development stage?

KW-2449 is in the early stages of testing, specifically Phase 1.

Does KW-2449 have known side effects?

There is currently no information available regarding common or serious side effects for KW-2449 in this data.

Can I take KW-2449 with other medications?

Information regarding drug interactions for KW-2449 is not yet available.

Kw-2449 | CAS 1000669-72-6 | YYLKKYCXAOBSRM

Loading compound...

Small molecule experimental drug

KW-2449 is an experimental small molecule currently being studied for its potential to treat acute myeloid leukemia. It is still in the early stages of clinical development.

How it worksKW-2449 is a small molecule being investigated for its activity against specific biological targets related to leukemia.

Used for

acute myeloid leukemia

Conditions

acute myeloid leukemia

Class

Small moleculeSmall molecule experimental drug

How to take

This drug is currently in Phase 1 of clinical development and is not yet approved for general use.

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Frequently asked questions (6)